Skip to main content

Table 1 Activities comprising the consensus meeting and the time dedicated to each

From: Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis

Time allocation (minutes)

Activity

Day 1

 

30

An introduction to the study and study endpoints

45

Review of current treatments, trial treatments, and associated current evidence base

105

Introduction to Bayesian methods

Day 2

 

30

Recap from Day 1

60

Formal elicitation exercise

30

Presentation of the individual priors

75

Group discussion to reach consensus

15

Presentation of consensus priors